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Abstract: Radial flow perfusion of cell-seeded hollow cylindrical porous scaffolds may 
overcome the transport limitations of pure diffusion and direct axial perfusion in the 
realization of bioengineered substitutes of failing or missing tissues. Little has been 
reported on the optimization criteria of such bioreactors. A steady-state model was 
developed, combining convective and dispersive transport of dissolved oxygen with 
Michaelis-Menten cellular consumption kinetics. Dimensional analysis was used to 
combine more effectively geometric and operational variables in the dimensionless groups 
determining bioreactor performance. The effectiveness of cell oxygenation was expressed 
in terms of non-hypoxic fractional construct volume. The model permits the optimization 
of the geometry of hollow cylindrical constructs, and direction and magnitude of perfusion 
flow, to ensure cell oxygenation and culture at controlled oxygen concentration profiles. 
This may help engineer tissues suitable for therapeutic and drug screening purposes. 
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Nomenclature 
C  dissolved oxygen concentration in the construct [mol/m3] 
CC  cell concentration in the construct [cells/m3] 
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Co  dissolved oxygen concentration in the feed [mol/m3] 
D  oxygen diffusion coefficient in water [m2/s] 
Darad,min = VmaxδC/(voCo)  minimal radial Damköhler number in the construct [-] 
DC  oxygen dispersion coefficient in the construct [m2/s] 
Deff = D·ε  effective oxygen diffusion coefficient in the construct [m2/s] 
G  maximal cell-specific oxygen metabolic consumption rate [mol/(s cell)] 
KM  Michaelis constant for oxygen consumption [mol/m3] 
k  Darcy permeability of construct [m2] 
L  construct length [m] 
NHy-FCV  non-hypoxic fractional construct volume [-] 
P  pressure [Pa] 
Peax = uo·L/DC   axial Peclet number [-] 
Perad,max = vo·δC/DC   maximal radial Peclet number [-] 
Q  medium feed flow rate [m3/s] 
Ri  construct inner radius [m] 
Ro  construct outer radius [m] 
r  radial coordinate [m] 
u  axial superficial velocity [m/s] 
uo  axial superficial velocity entering the construct [m/s] 
Vmax = CCG  maximal metabolic consumption rate of oxygen [mol/(m3s)] 
v  radial velocity in construct [m/s] 
vo  maximal radial velocity in construct at r = Ri [m/s] 
z  axial coordinate [m]  
Greek Symbols 
β = KM/Co  saturation parameter [-] 
γ  perfusion flow direction parameter [-] 
δC = Ro − Ri  thickness of construct annular wall [m] 
ε  construct porosity [-] 
μ  medium viscosity [Pa·s] 
φC = √(Vmax·δC/(DC·Co))  Thiele modulus in construct perfused with medium [-] 
φD = √(Vmax·δC/(Deff·Co)) Thiele modulus in construct under static operation [-] 
τ  average shear stress in construct [Pa] 
Superscripts and Subscripts 
ax  axial 
C  construct 
max  maximal 
rad  radial 
*  dimensionless 
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1. Introduction 
In recent years, the scarcity of donor tissue to replace the mechanical or metabolic functions of 
missing or failing tissue has prompted the search for alternative treatments [1]. An interesting 
alternative to tissue replacement with artificial grafts and to animal models for in vitro drug screening 
is to engineer biological substitutes of human tissue by seeding isolated autologous cells in  
three-dimensional (3D) porous scaffolds and by guiding cell re-organization and differentiation in 
bioreactors in which cells are subject to physiological mechanical and biochemical cues. In the repair 
of large bone defects, the presence of autologous cells could eliminate rejection of allo- or xenografts 
and could enhance graft osteointegration as compared to artificial bone grafts [2]. In the extracorporeal 
assist to liver failure patients, treatments based on bioreactors using engineered liver tissue could 
provide the patient with more liver-specific functions (virtually all of them) than non-specific artificial 
treatments and bioreactors using immortalized cell lines or enzymes [3]. 
An important step in the realization of clinical-scale engineered tissue is the construct culture in 
bioreactors designed and operated in such a way to guide cell re-organization and differentiation as in 
the natural tissue. Cell culture in the presence of controlled physiological concentrations and supply of 
nutrients and dissolved oxygen is a basic bioreactor requirement to ensure cell survival and to make 
cells differentiate to a given phenotype. In particular, oxygen is acknowledged a major limiting role to 
the development of engineered substitutes mimicking natural tissues [4–8]. Metabolic soluble species 
are generally supplied in the culture medium. To reach the cells anywhere in the construct, such 
solutes have to be transported external to the construct (i.e., from the medium bulk to the construct 
outer surface) and inside the construct (i.e., from its outer surface to the innermost regions) across the 
cell mass [9]. Pure diffusive transport in static bioreactors ensures dissolved oxygen and nutrients 
supply only to a distance about 100 μm away from the construct outer surface, it subjects cells to 
oxygen and nutrients concentrations largely varying in space (e.g., across the construct), and ultimately 
limits the realization of clinical-scale 3D cell constructs [10–14]. To minimize the diffusive limitations 
to external solute transport, bioreactors have been proposed in which some degree of external 
convection is superimposed over pure diffusion by perfusing the medium around or along the 
construct. Radial medium perfusion along two-dimensional (2D) cultures of liver cells in a gel 
sandwich adherent to glass discs [15] or constrained between microporous membranes encased in a 
rigid frame [16] permits the design of more compact bioreactors than the typical flasks or dishes. 
Medium convection around 3D porous constructs in spinner flasks and rotating wall vessel bioreactors 
has been reported to improve cell distribution and viability with respect to static bioreactors but has not 
been shown to permit adequate oxygen and nutrients supply to cells deep into the construct and 
adequate expression of cell differentiation markers [17–19]. Medium supplementation with carriers 
reversibly binding oxygen (e.g., cross-linked hemoglobins or perfluorocarbons) has also been proposed 
to mimic the oxygen storage function of hemoglobin in the red blood cells and overcome the low 
solubility of oxygen in aqueous media [20,21]. The inclusion of porous hydrophobic microspheres in 
3D collagen gel constructs has been shown to enhance oxygen diffusive transport, and increase the 
oxygen penetration depth, into the construct and hepatocyte functions by promoting some degree of 
local natural convection at the gel interface with the microspheres [22,23]. Direct axial perfusion of 3D 
porous constructs with medium in axial-flow packed bed bioreactors (aPBBs) uses convection to 
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enhance oxygen and nutrients transport to cells internal to the construct [24–27]. However, at low axial 
superficial velocity the dissolved oxygen and nutrients concentrations may steeply decrease towards 
the end of the construct leading to poor cell nourishment and causing the formation of a necrotic end 
zone [28,29]. Cell perfusion at high axial superficial velocity to keep cells viable and differentiated 
anywhere in the construct may cause cell wash-out [30]. 
Radial perfusion with medium of cells seeded in 3D cylindrical porous scaffolds with a coaxial 
hollow cavity has been proposed to overcome the transport limitations of pure diffusive operation and 
direct axial perfusion [31]. Similar to axial perfusion, superimposition of convection to pure diffusion 
should enhance solute transport to cells. Radially perfused hollow constructs would also feature a 
larger cross-sectional area for solute transport and shorter solute transport path-length than axially 
perfused constructs. Hence, cell constructs could be cultured in radial-flow packed-bed bioreactors 
(rPBBs) at lower pressure drop and lower superficial velocity (hence lower shear stresses) than aPBBs 
and still enable cell culture under smoother and more controllable dissolved oxygen and nutrients 
concentration gradients in the direction of medium perfusion [32]. This is a very interesting feature to 
control cell pericellular environment and to guide cell differentiation when realizing biological tissue 
substitutes for implantation or for the in vitro toxicity screening of new drugs [33]. 
In spite of these interesting features, only a few reports have been published on the culture of 
human cells seeded in 3D porous scaffolds in radial-flow packed-bed bioreactors for therapeutic 
applications. Inward radial perfusion of 3D constructs in rPBBs has been shown to promote cell 
proliferation to a greater extent than static operation in the culture of NIH/3T3 cells in poly(L)lactic 
acid porous scaffolds [34], and of sheep mesenchymal stem cells [35] and MG63 osteoblast-like  
cells [36] in β-tricalcium phosphate (β-TCP) porous scaffolds. In the development of a bioartificial 
liver, inward radial perfusion culture in rPBBs has been reported to maintain in an active metabolic 
state high concentrations of human liver cancer cells FLC-7 [37], HepG2 cells [38], and porcine 
hepatocytes [39] in small-scale constructs, and of porcine primary hepatocytes in clinical-scale 
constructs [40,41]. The co-culture in rPBBs of immortalized [42] and primary fetal hepatocytes and 
non-parenchymal cells [43] in a 3D porous scaffold perfused inwards has been reported to promote the 
partial organization of cells in a liver-like architecture with sinusoid-like lumen structures and 
sustained liver-specific functions for a week. Olivier et al. [36] reported that inward medium perfusion 
enhances MG63 cell proliferation and metabolic activity in β-TCP porous scaffolds to a greater extent 
than outward medium perfusion. 
In the absence of thorough experimental information, the peculiar features of rPBBs could be 
exploited with the help of mathematical models of momentum and solute transport across the 
construct. In this paper reference is mainly made to the few models proposed for mammalian cell 
culture in rPBBs because they account for some typical cell features, such as the sensitivity of their 
metabolism to the culture environment (e.g., pericellular dissolved oxygen and nutrients concentration, 
shear stress, pressure), and the fact that some cell types proliferate during culture thus changing both 
the geometry of the flow channel and the conditions under which the bioreactor is operated, among 
others. All models propose a pseudo-homogeneous description of transport across the construct, and 
neglect transport in the inner hollow cavity and the peripheral annular space. Tharakan and Chau [44] 
proposed a steady-state transport model of the limiting metabolic substrate and the products across an 
annular bed of mammalian cells perfused outwards with medium for the production of monoclonal 
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antibody. The model accounts for dispersive and convective solute radial transport across the cell 
construct, for substrate consumption in terms of the Monod kinetics and for the possible presence of 
semipermeable membranes in the cell mass, albeit in lumped fashion. The model was used to 
investigate the effect of the dimensionless radial superficial velocity, the dimensionless construct 
thickness, and the cell metabolic activity on the substrate conversion to products and their distribution 
across the cell construct. Cima et al. [45] described the steady-state transport by diffusion and 
convection of dissolved oxygen and nutrients across an annular bed of cells seeded in the thin gap 
between two concentric thick-walled microporous hollow fiber membranes. Dimensionless analytic 
expressions for the dissolved oxygen and nutrients concentrations across the cell mass have been 
reported for zero-th order cellular consumption kinetics and for uniform solute concentrations in the 
inner fiber lumen and outside the outer fiber wall, equal to each other. The model was used to 
investigate the effect of the dimensionless radial superficial velocity and solute consumption rate on 
the dissolved oxygen and nutrients concentrations across the cell mass for a given hollow fiber 
membranes geometry, outward medium perfusion flow, and cells with low metabolic requirements. 
Böhmann et al. [46] developed and experimentally validated a lumped parameter model describing 
radial perfusion and metabolic consumption of dissolved oxygen across a 35 mm thick annular bed of 
SIRAN® macroporous beads wrapped in a dialysis membrane in which hybridoma cells were cultured. 
The model was used to investigate the influence of the concentration of low-molecular weight solutes, 
freely permeable across the membrane, and high molecular weight solutes, retained in the bed, on 
long-term monoclonal antibody production. The model enabled the bioreactor scale-up from a 0.1 L to 
a 5 L bed volume [47]. To the best of the authors’ knowledge a systematic analysis of the influence on 
bioreactor performance of dimensionless parameters accounting for the annular bed geometry and 
shape, a concentration-dependent solute consumption kinetics, and the direction of the perfusion flow 
under the constraints typical of therapeutic applications (e.g., the replacement of tissue structure or 
functions in therapeutic treatments or in the in vitro drug screening) has not been reported yet. This 
hinders recognition of the most relevant parameters determining the rPBB behavior and the 
understanding of the interplay among such parameters, and makes it difficult to optimize bioreactor 
design and operation for a given therapeutic objective. 
In this paper, it is proposed a model-based reference framework aimed to optimize scaffold 
geometry and operating conditions (i.e., direction and superficial velocity of the perfusing  
medium) of convection-enhanced rPBBs for therapeutic applications. The framework relies on a  
pseudo-homogeneous model based on the Darcy and the convection-dispersion-reaction equation to 
describe the pseudo steady-state transport of momentum and dissolved oxygen in annular porous 
constructs of varying geometry, which are perfused with medium flowing in different directions and in 
which human cells consuming oxygen according to Michaelis-Menten kinetics are cultured at varying 
concentrations. Dimensional analysis is used to identify the dimensionless groups determining the 
bioreactor performance expressed in terms of a more apt parameter to therapeutic applications. The 
aim is to provide the bioreactor designer with a tool for helping in the optimization of design and 
operation of convection-enhanced rPBBs and for enabling control of the pericellular concentrations of 
dissolved oxygen, but also of low molecular weight nutrients and biochemical cues, to prevent cell 
starvation, to guide their differentiation towards a given phenotype, and to assess drug toxicity under 
known environmental conditions and cell state. 
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2. Materials and Methods 
2.1. Model Development 
2.1.1. Convection-Enhanced Transport Model of rPBB 
A model was developed to describe the transport of momentum and low molecular weight solutes in 
convection-enhanced radial packed-bed bioreactors. The attention was focused on oxygen for its 
importance to cell metabolism [4–8]. Schemes of an rPBB with opposite perfusion flows are reported 
in Figure 1. The bioreactor consists of a cylindrical chamber equipped with inlet and outlet fittings in 
which it is located a 3D cylindrical porous scaffold of length L, outer radius Ro, and porosity ε, with a 
coaxial hollow cavity of radius Ri. Human cells are seeded and cultured at a concentration CC in the 
pores of the construct annular wall of thickness δC. Medium of viscosity μ carrying oxygen at a 
concentration Co is fed to the bioreactor at a flow rate Q and continuously flows radially across the 
construct from the outer peripheral annular space towards the inner hollow cavity (i.e., inwards),  
as shown in Figure 1a, or from the inner hollow cavity towards the outer peripheral annular space  
(i.e., outwards), as shown in Figure 1b, at a maximal superficial velocity vo at the inner construct 
surface (i.e., r = Ri). In the inner hollow cavity and the peripheral annular space medium is assumed to 
flow axially in opposite directions and is assumed well-mixed (i.e., solute concentration is uniform 
throughout). The flow configurations considered are often referred to as CP-π flow (or centripetal) 
(Figure 1a) or CF-π flow (or centrifugal) (Figure 1b) [48]. The term π-flow indicates that medium flow 
directions in the inner hollow cavity and the peripheral annular space are opposite. Dissolved oxygen 
is carried by the medium into the construct where it is transported to the cells by convection  
(i.e., associated to the net medium flow) and dispersion with a dispersion coefficient DC (i.e., transport 
is promoted by a concentration gradient in the presence of the flowing medium), and it is metabolized 
by the cells. At low medium superficial velocity across the construct, the concentration gradient-driven 
oxygen transport occurs mainly by diffusion [49]. At high medium superficial velocity, the mixing 
generated by the medium flowing across the porous scaffold becomes important and the concentration 
gradient-driven oxygen transport is mainly dispersive [49]. The conservation equations governing the 
rPBB performance were obtained under the following assumptions: 
1. axial symmetry; 
2. steady-state conditions; 
3. incompressible fluid; 
4. isothermal conditions; 
5. transport in the construct is described according to a pseudo-homogeneous approach; 
6. construct is described as an isotropic porous medium with Darcy permeability k; 
7. uniform cell distribution CC; 
8. no cell lysis or apoptosis; 
9. solute concentration in the construct does not vary along the axial and angular coordinates; 
10. momentum transport in the construct is described according to the Darcy equation; 
11. dissolved oxygen is transported across the construct by convection and dispersion; 
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12. cells consume oxygen according to Michaelis-Menten kinetics, with a maximal cell-specific 
consumption rate G and a Michaelis constant KM. 
Under these assumptions, upon introducing the following non-dimensional coordinates and variables 
* * * * M
2
i o i o o
; ; ; ; βμ /o
Kr v P Cr v P C
R v v L R C C
= = = = =  (1)
the governing conservation equations in the construct may be re-arranged in dimensionless form to give: 
continuity equation 
*
* 1
r
v =  (2)
momentum conservation (Darcy equation) 
*
*
3 *
i
dγ
d
kL Pv
R r
=−  (3)
mass conservation 
2* * *
* * 2i i
,max * * * * 2 *
C C
d 1 d d γ φδ d d d δ βrad C
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r r r r C
   
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+   
 (4)
where γ = 1 in the case of outward flow, and γ = −1 in the case of inward flow. Equation (3) is subject 
to the boundary condition stating that the outlet pressure equals atmospheric pressure, as follows: 
B.C.1 
* *C
i
δ(γ 1) 1 0;outward flow r P
R
= = + =  (5a) 
* *(γ 1) 1 0;inward flow r P= − = =  (5b) 
Equation (4) is subject to two boundary conditions, of which B.C.2 states the continuity of solute flux 
at the entrance to the construct in terms of Danckwert’s condition, and B.C.3 states the continuity of 
fluxes across the outer construct surface when solute concentration does not change any further once 
the medium leaves the construct, as follows: 
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when Perad,max >> 1, Equations (6a,b) states that solute concentration in the stream entering the 
construct equals that in the feed. 
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Figure 1. Scheme of radial flow packed-bed bioreactors (rPBBs) with opposite perfusion 
flows across the annular construct wall: (a) inward flow; (b) outward flow. 
2.1.2. Diffusion-Limited Transport Model of rPBB 
For the sake of comparison, a diffusion-limited model of solute transport in the rPBB was also 
developed. In this case, the construct is assumed to be dipped and held suspended in medium carrying 
oxygen at a concentration Co in a reservoir and medium has unhindered access to the hollow cavity. 
Under the same assumptions as in the convection-enhanced transport model, but for the fact that 
oxygen transport occurs only by diffusion with an effective diffusion coefficient Deff, and for the same 
non-dimensional coordinates and variables as in Equation (1), the governing mass conservation 
equation in the construct may be re-arranged in dimensionless form to give: 
2* *
* 2 i
D* * * 2 *
C
1 d d φ
d d δ β
RC Cr
r r r C
 
= 
+ 
 (8)
which is subject to two boundary conditions stating that both the inner and the outer construct surfaces 
are exposed to the same dissolved oxygen concentration in medium Co (i.e., well mixed reservoir): 
B.C.1 
11 ** == Cr  (9a) 
B.C.2 
* *C
i
δ1 1r C
R
= + =  (9b) 
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2.1.3. Convection-Enhanced Transport Model of aPBB 
To compare the rPBB performance to that of an aPBB, reference was made to the dimensionless 
design equations of aPBBs in which medium carrying oxygen at a concentration Co perfuses at an axial 
superficial velocity uo a cylindrical construct of length L and radius Ri, as in [50]. Under the  
same assumptions as in the convection-enhanced transport model of rPBB, and for the same  
non-dimensional coordinates and variables as in Equation (1) but for z* = z/L, the governing mass 
conservation equation in the construct may be re-arranged in dimensionless form to give: 
momentum conservation (Darcy equation) 
*
*
2 *
i
d
d
k Pu
R z
=−
 (10)
mass conservation 
* 2 * *
* 2
C* *2 *
d d φ
d d βax
C C CPe u
z z C
 
= − 
+ 
 (11)
Equation (10) is subject to the boundary condition stating that the outlet pressure equals atmospheric 
pressure, as follows: 
B.C.1 
01 ** == Pz  (12) 
Equation (11) is subject to two boundary conditions of which B.C.2 states the continuity of solute flux 
at the entrance to the construct in terms of Danckwert’s condition, and B.C.3 the continuity of fluxes 
across the outer construct surface when solute concentration does not change any further once the 
medium leaves the construct, as follows: 
B.C.2 
*
* *
*
1 d0 1
dax
Cz C
Pe z
= = −
 (13a)
B.C.3 
*
*
*
d1 0
d
Cz
z
= =
 (13b)
2.2. Dimensionless Groups 
2.2.1. Convection-Enhanced Transport Model of rPBB 
Analysis of dimensionless Equations (1)–(7) shows that the rPBB performance is determined by the 
six dimensionless groups reported in Table 1. The physical interpretation of most of these 
dimensionless groups is well established [51]. The dimensionless group k L/Ri3 may be interpreted as 
the dimensionless Darcy permeability of the construct and provides information about the radial 
pressure drop across the construct at a given flow rate. The higher its value, the lower the radial 
pressure drop across the construct. The construct inner radius-to-wall thickness ratio, Ri/δC, accounts 
for the construct curvature. The higher the inner radius or the thinner the thickness of the annular wall, 
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the more negligible the construct curvature. The maximal radial Peclet number, Perad,max, compares the 
maximal rate of solute transport in the construct by convection to dispersion. The higher its value, the 
higher the importance of convection to solute transport as compared to dispersion. The Thiele modulus 
compares the maximal zero-th order solute consumption rate, Vmax = CC·G, to the maximal rate of 
dispersive solute transport, Co DC/δC2. High Thiele moduli may be associated with high cell 
concentrations, CC, or high cell-specific metabolic consumption rates, G. The saturation parameter β 
provides information on the extent to which the consumption kinetics differs from the zero-th order. 
The higher its value, the closer the kinetics to the first order. 
Table 1. Dimensionless groups determining the rPBB performance. 
Group Definition Description 
1. γ perfusion flow direction parameter 
2. k L/Ri3 dimensionless Darcy permeability of construct 
3. Ri/δC inner radius-to-thickness ratio of the construct 
4. vo δC/DC maximal radial Peclet number, Perad,max 
5. √(VmaxδC2/(DC Co)) Thiele modulus, φC 
6. KM/Co saturation parameter, β 
2.2.2. Diffusion-Limited Transport Model of rPBB 
Analysis of dimensionless Equations (8) and (9) shows that under diffusion-limited operation, the 
performance of the rPBB is determined only by the construct curvature, Ri/δC, the Thiele modulus  
φD = √(Vmax δC2/(Deff Co)) and the saturation parameter β = KM/Co. 
2.2.3. Convection-Enhanced Transport Model of rPBB 
Analysis of dimensionless Equations (10)–(13) shows that the dimensionless groups determining 
the performance of an axial-flow packed bed bioreactor are the dimensionless Darcy permeability of 
the construct, k/Ri2, the axial Peclet number, Peax = uo L/DC, the Thiele modulus φC = √(Vmax L2/(DC Co)) 
and the saturation parameter β = KM/Co. 
2.3. Computational Methods 
The resulting set of governing equations for a convection-enhanced or a diffusion-limited rPBB, 
and for an aPBB, was integrated numerically with the commercial Finite Element Method (FEM) code 
Comsol Multiphysics (Comsol Inc., Burlington, MA, USA). An optimal non-uniform mesh with more 
than 20,000 rectangular elements, finer at the construct inner and outer surfaces, was generally used to 
describe the spatial domain. Model-predicted spatial profiles of superficial velocity, pressure and 
dissolved oxygen concentration were obtained for values of the model parameters and dimensionless 
groups representative of those used in experiments in which rPBBs were used, or typically reported or 
of interest for therapeutic applications, as reported in Tables 2 and 3 unless otherwise stated. In 
particular, the effective diffusivity of oxygen, Deff, was estimated according to [50] by multiplying  
that in water at 37 °C [52] by a construct porosity ε = 0.7, typical of the 3D porous scaffolds used in  
rPBBs [35,36]. The dispersion coefficient for oxygen in the construct was estimated by adjusting the 
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diffusivity according to the correlations for liquids in [49] for the value of the maximal radial 
superficial velocity, vo. The value of vo was set equal to 1.98 × 10−4 m/s throughout, consistent with the 
values used in the few culture experiments reported for rPBBs with small-scale constructs seeded with 
human cells [35,36]. 
Table 2. Dimensionless group values used for model predictions, unless otherwise stated. 
Dimensionless Group Values 
1. perfusion flow direction parameter, γ −1 (inwards), 1 (outwards) 
2. dimensionless Darcy permeability of construct, k L/Ri3 2.24 × 10−10−2.24 × 10−4 
3. construct curvature, Ri/δC 0.1–10 
4. maximal radial Peclet number, Perad,max 49 
5. Thiele modulus, φC or φD 1–20 
6. saturation parameter, β 0.019 
Table 3. Model parameter values used for model predictions, unless otherwise stated. 
Symbol Model Parameter Value Units Reference
Co oxygen inlet concentration 0.216 mol/m3 [53] 
D oxygen diffusivity in water 2.64 × 10−9 m2/s [52] 
Deff effective oxygen diffusivity in the construct 1.85 × 10−9 m2/s [50] 
DC oxygen dispersivity in the construct 2 × 10−8 m2/s [49] 
KM oxygen Michaelis constant 4.05 × 10−3 mol/m3 [54] 
k Darcy permeability of construct 1.4 × 10−13 m2 [55] 
L scaffold length 0.2 m  
vo maximal inlet superficial velocity 1.98 × 10−4 m/s [36] 
δC scaffold thickness 0.005 m [36] 
μ medium viscosity 6.92 × 10−4 Pa s [53] 
Although the spatial dissolved oxygen concentration profiles are essential to assess the actual 
pericellular culture conditions, a more helpful approach to the first decisional phases of design is to 
condense bioreactor performance in one parameter only, and to analyze the influence of the most 
relevant dimensionless groups on this performance parameter. With respect to oxygen, the basic 
requirement for cell survival is that cells should be supplied with physiological amounts of oxygen and 
should be cultured at physiological dissolved oxygen concentrations anywhere in the construct. To this 
purpose, an alternative performance parameter was introduced that was deemed more significant to 
bioreactor designers for therapeutic applications. It provides information on the volume fraction of  
the construct in which cells are exposed to physiological dissolved oxygen concentrations, and was 
termed the non-hypoxic fractional construct volume (NHy-FCV). In this work, the minimal value  
for physiological oxygen concentrations was set equal to 2 × 10−2 mM, a typical threshold for 
mammalian cells [56]. 
3. Results and Discussion  
Radial-flow packed bed bioreactors have distinctive features that make them interesting for 
therapeutic applications. Their structure resembles the architecture of long bones (e.g., the femur shaft) [57] 
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and the medium perfusion pattern is similar to blood in the liver lobule [58], when the construct is 
perfused inwards. Radial perfusion enhances solute transport to cells with respect to pure diffusion. 
Radially perfused hollow cylindrical constructs feature also a larger cross-sectional area and a shorter 
path-length for solute transport than axially perfused constructs. In this paper, a model reference 
framework is proposed to help designers of rPBBs optimize their geometry and operation to meet 
given therapeutic requirements. The framework is based on the model described by Equations (1)–(9) 
in which the pseudo steady-state transport of momentum and dissolved oxygen across an annular  
cell-seeded construct is described according to the Darcy and the dispersion-convection-reaction 
equation, respectively. The dimensionless groups determining the actual dissolved oxygen 
concentration profile in the construct and the performance of the rPBB were obtained by dimensional 
analysis of Equations (1)–(9) and are shown in Table 1. The pseudo steady-state assumption is not a 
limitation to the use of the model. In fact, the large difference in the time scale typical of bioreactor 
dynamics (of the order of the minute) and of the kinetics of cell growth (of the order of the day), 
makes it possible to use the model for investigating bioreactor performance as cells proliferate and/or 
secrete an own ECM by adjusting the dimensionless groups values to the maturation of the cell 
construct. Another important assumption in the model development is that medium flows at uniform 
superficial radial velocity along the bioreactor length. In fact, maldistribution of radial velocity has 
been reported to have more influence on the performance of radial-flow packed bed reactors for 
industrial applications than other parameters, such as the flow direction [59]. In the use of rPBBs for 
human cell culture, a non-uniform superficial radial velocity would cause a non-uniform supply of 
dissolved oxygen, nutrients and biochemical cues to cells that, during culture, might yield a  
non-uniform cell distribution in the construct as an effect of poor cell proliferation or cell necrosis in 
the poorly perfused regions of the construct. As tissue matures, this would cause the Darcy 
permeability of the construct to decrease non-uniformly thus worsening even further the radial flow 
maldistribution and its effects. As Figure 1 shows, in the model development reference was made to 
rPBBs in which the directions of axial flow in the inner hollow cavity and the outer peripheral annular 
space are opposite, i.e., a π-flow type bioreactor configuration, to make it more likely that the actual 
radial superficial velocity be uniformly distributed along the bioreactor length under actual operation. 
In fact, if the frictional pressure drop is negligible in the inner hollow cavity and the outer peripheral 
annular space, independent of the flow direction, the axial pressure profiles in these regions develop in 
such a way to maintain a constant radial pressure drop across the construct [48]. 
The scarcity of experimental data for human cell culture in convection-enhanced rPBBs and the 
difficult procurement of detailed information on the conditions and geometry used made it awkward  
to validate the model. For these reasons, model goodness was assessed by comparing the  
model-predicted dissolved oxygen concentration profiles across the annular constructs to those 
predicted by Cima et al. [45] and the model-predicted glucose consumption, to that reported by  
Olivier et al. [36] for the culture of osteosarcoma cells in an rPBB perfused with medium both inwards 
and outwards, as shown in Figure 2. In the latter case, the rPBB was assumed to be connected in closed 
loop to a completely mixed reservoir, and its dynamics was neglected with respect to the reservoir on 
the account of its small volume. Glucose consumption was estimated from the model-predicted 
decrease of glucose concentration in the reservoir after 24 h. Figure 2a shows that the predictions of 
the model presented in this paper were in good agreement with those reported by Cima et al., for the 
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geometry and the operating conditions used therein, i.e., zero-th order consumption kinetics, Thiele 
moduli typical of cells with low metabolic requirements, and exposure of the construct inner and outer 
surfaces to equal dissolved oxygen concentrations [45]. Figure 2b shows that the model effectively 
predicted also the experimental results reported by Olivier et al., for the culture of osteosarcoma cells 
in an rPBB [36]. In this case, the cell-specific glucose consumption rate was estimated with the 
diffusion-limited transport model as that best fitting the experimental data reported for static culture in 
the rPBB. When medium was perfused outwards, the decreased cell concentrations that were observed 
by Olivier et al. in the construct, likely as an effect of cell wash-out, were taken into account. 
Figure 2. Comparison of model-predicted low molecular weight substrate concentrations 
to: (a) the theoretical predictions for dissolved oxygen of Cima et al. [45]; (b) the 
experimental data for glucose consumption of Olivier et al. [36]. Predictions obtained for 
the following parameter values: (a) γ = 1, Ri/δC = 1.49, Perad,max = 0.67, k L/Ri3 = 1.5 × 10−2,  
φC = 1.16 (●) and 1.34 (■); (b) Ri/δC = 0.4, Perad,max = 1071, k L/Ri3 = 2.5 × 10−7,  
φC = 0.82−0.93, β = 0.02, for perfusion inwards γ = 1 (♦), outwards γ = −1 (■), or static 
operation (x). 
Model predictions show the convenient characteristics of radial-flow packed bed bioreactors as 
compared to static operation and axial-flow packed bed bioreactors in the culture of cell-seeded 
constructs. Figure 3 shows that radial perfusion in an rPBB may yield better oxygen supply to cells 
anywhere in the construct and more uniform pericellular dissolved oxygen concentrations than static 
operation. In spite of the fact that under static operation oxygen is supplied to cells through both the 
inner and the outer construct surfaces, when transport is diffusion-limited the dissolved oxygen 
concentration steeply decreases towards the innermost regions of the annular construct. Oxygen 
depletion gets worse when highly concentrated cells with high metabolic requirements are cultured, 
i.e., as the Thiele modulus increases. Figure 3a,b shows that under static operation for  
Vmax = 1.76 × 10−9 mol/(mL s) cells would be cultured under anoxic conditions in about 65% of  
the construct volume. This could be the case of osteoblasts consuming oxygen at  
G = 5.5 × 10−17 mol/(s cell) [60] cultured in a 3D porous hollow cylindrical scaffold at a concentration 
of CC = 3.2 × 107 cells/mL [26]. When the same construct is radially perfused with medium at  
Perad,max = 49, independent of the direction of the perfusion flow, the radial dissolved oxygen 
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concentration profile is about uniform across the construct at the same value as in the feed  
as long as the cell-specific oxygen consumption rate and cell concentration yields Vmax up to  
ca. 1.8 × 10−10 mol/(s mL). Independent of the flow direction, at higher Thiele moduli the dissolved 
oxygen concentration smoothly decreases along the direction of medium perfusion. Figure 3a,b shows 
that for Vmax = 1.76 × 10−9 mol/(s mL) the minimal dissolved oxygen concentration nowhere gets 
below ca. 50% of that in the feed. Such a remarkable transport enhancement may be attributed directly 
to convection, but also to the convection-related increase of the dispersion coefficient. 
Figure 3. Dimensionless radial oxygen radial concentration profiles at varying maximal 
oxygen consumption rates Vmax: (i) 1.76 × 10−10 mol/(s mL); (ii) 8.8 × 10−10 mol/(s mL); 
(iii) 1.76 × 10−9 mol/(s mL) for cells cultured in a hollow cylindrical construct in an rPBB 
radially perfused with medium (solid lines) (a) outward or (b) inwards, or (dashed lines) 
statically operated. Parameter values: Ri/δC = 0.4, Perad,max = 49. Other parameters are as in 
Tables 2 and 3. 
The performance of an rPBB was compared to that of an aPBB for the case of the bioengineering of 
a clinical-scale long bone graft (e.g., a femur shaft) or of a bioreactor for a bioartificial liver (BAL), 
under the constraint that the construct length and volume, and the maximal superficial velocity be 
equal to the aPBB. For the superficial velocity this means that vo = uo. In the case of the aPBB, the 
bioengineered femur shaft was approximated with a cylindrical porous construct 40 cm long and  
3.5 cm in diameter, similar in size to the human femur shaft [57], and the bioreactor for BAL was 
assumed to be based on a cylindrical porous construct 20 cm long and 3 cm in diameter so as to be 
easily fitted in the housing of some clinical-scale BAL bioreactors proposed in the last years [19]. In 
either case, the rPBB was assumed to be equipped with a cylindrical construct of equal length and 
volume with an inner hollow cavity of radius Ri = 5 mm. For the bone graft, the constructs were 
assumed to be seeded with 107 osteoblasts/mL consuming oxygen at 5.5 × 10−17 mol/(cell s) [60]. For 
the liver graft, it was considered the possibility that the constructs are seeded with either hepatocytes 
or HepG2 cells, consuming oxygen at 9 × 10−16 mol/(cell s) [61] or 6.62 × 10−17 mol/(cell s) [62], 
respectively. Radial medium perfusion across the construct generally yields dissolved oxygen 
concentration profiles, which decrease more smoothly in the direction of medium perfusion than in 
aPBBs. In the case of the bioengineered long bone graft, Figure 4a shows that in an aPBB  
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the dissolved oxygen concentration steeply decreases away from the entrance. This results in a  
non-hypoxic fractional construct volume of only NHy-FCV = 0.18 and causes cells to be cultured 
under anoxic conditions in about 78% of the construct volume. Figure 4b shows that in an rPBB the 
dissolved oxygen concentration in the construct decreases more smoothly in the direction of the 
perfusion flow and it is nowhere below 62% of the feed, largely exceeding the set physiological 
threshold value. Similar results were obtained in the case of bioreactors for BAL seeded with the HepG2 
immortalized cell line (data not shown). Oxygen depletion was much more severe in bioreactors 
seeded with primary hepatocytes causing cells to be cultured under anoxic conditions in more than 
60% of the construct volume. However, in the rPBB the well oxygenated fractional construct volume 
was about fifteen fold higher than in the aPBB (31% vs. 2%, respectively). The transport enhancement 
in the rPBB may be attributed to the shorter oxygen transport path-length than the aPBB (i.e., the 
construct annular thickness vs. length) that apparently more than compensates for the fact that the  
axial Peclet number in the aPBB is more than one order of magnitude higher than the maximal radial 
Peclet number in the rPBB. Bioreactor performance was compared at vo = uo = 1.98 × 10−4 m/s because 
this would guarantee that cells are not damaged by shear stresses. In fact, if the average shear stress 
acting on cells for medium perfusion in the construct is estimated according to [63], as follows: 
oμτ v
k
=  (14)
it may be estimated that τ = 0.35 Pa in both bioreactors. This is below the reported range of laminar 
shear stress at which adherent cells are removed from surfaces [64]. However, the maximal pressure 
drop across the axially perfused construct is about two orders of magnitude higher than in the radially 
perfused construct which may compress or even crush soft scaffolds and cause mechanical damage to 
cells or cell wash-out. Increasing uo in the aPBB to obtain a smoother axial dissolved oxygen 
concentration profile would cause an even greater increase of the axial pressure drop that may worsen 
these effects. 
Figure 4. Dimensionless oxygen concentrations in a 3D porous bone construct perfused 
with medium: (a) axially (Peax = 3910); (b) radially outwards (Perad,max = 129, Ri/δC = 0.38, 
γ = 1). Parameter values: CC = 107 cell/mL, G = 5.5 × 10−17 mol/(s·cell), L = 40 cm. Other 
parameters are as in Tables 2 and 3. 
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In the reports published on convection-enhanced rPBBs, it has not been paid much attention to the 
effect of the construct curvature on rPBB performance. In the model proposed in this paper, the 
construct curvature is accounted for by the ratio of the inner hollow cavity radius to the construct 
annular thickness, Ri/δC. Model-predicted dissolved oxygen concentration profiles were obtained at 
varying values of this dimensionless group by keeping δC constant and by varying the construct inner 
radius Ri to avoid changes of the other dimensionless groups. This way, dimensionless groups such as 
the Perad,max and φC, as well as the oxygen transport path-length and medium residence time, were kept 
constant. Figure 5 shows the dissolved oxygen concentration profiles across the annular wall of 
constructs featuring two values of Ri/δC an order of magnitude different, at increasing Thiele moduli. 
At any given Ri/δC, the dissolved oxygen concentration decreases in the direction of medium perfusion 
with a steeper slope as the Thiele modulus increases. Figure 5 shows that in constructs with greater 
curvature, i.e., lower Ri/δC, increasing Thiele moduli cause a greater oxygen concentration decay along 
the direction of medium perfusion than in constructs with smaller curvature, i.e., higher Ri/δC.  
Figure 5a shows that for Ri/δC = 0.1 and φC = 4 cells are cultured under hypoxic conditions in about 
32% of the construct volume. Figure 5b shows that at Ri/δC = 1 and φC = 4 the dissolved oxygen 
concentration profile is much smoother and oxygen concentration is above 50% of the feed almost 
everywhere in the construct. This suggests that constructs of smaller curvature, i.e., higher Ri/δC, may 
help obtain more uniform dissolved oxygen concentration profiles throughout the construct in all those 
applications in which the control of the pericellular environment is important (e.g., in the in vitro 
toxicity test of drugs). 
Figure 5. Model-predicted dimensionless oxygen concentrations along the annular wall of 
constructs, cultured in an rPBB and perfused outwards with medium (i.e., γ = 1), featuring 
different curvature: (a) Ri/δC = 0.1; (b) Ri/δC = 1. Other parameters as in Tables 2 and 3. 
In the first decisional phases of the design of rPBBs it may be convenient to condense the bioreactor 
performance in one parameter only, and to analyze the influence of the most relevant dimensionless 
groups on this performance parameter. The basic requirement for human cell culture for therapeutic 
treatments (as well as for the in vitro drug testing) is that cells are viable and express differentiated 
tissue-specific functions for the duration of the treatment (or the in vitro test). Culturing cells at 
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controlled pericellular dissolved oxygen concentrations within the physiological range of the specific 
cell niche seems a reasonable approach to avert cell death by anoxia or by hyperoxic poisoning [65]. In 
this paper, the performance of the rPBB was condensed in the non-hypoxic fractional construct volume 
(NHy-FCV). When oxygen convective transport becomes important, the balance between the rate of 
physical transport and metabolic consumption is better evaluated in terms of the Damköhler number 
rather than the Thiele modulus. In rPBBs, the radial superficial velocity varies along the construct 
radius. A minimal radial Damköhler number Darad,min may be defined as the ratio of the squared Thiele 
modulus to the maximal radial Peclet number, Darad,min = φC2/Perad,max. Figure 6 shows how the  
NHy-FCV varies with increasing Darad,min at values of the curvature, Ri/δC, varying by three orders of 
magnitude, for both inward and outward medium perfusion. Independent of the direction of medium 
perfusion and Ri/δC, at sufficiently low Darad,min the bioreactor is operated under kinetic control, i.e., 
the dissolved oxygen concentration profile is nearly uniform in the construct, and NHy-FCV 
approaches unity. At high Darad,min the bioreactor is operated under transport control, i.e., winning the 
transport resistance requires significant amounts of the oxygen supplied, and NHy-FCV is lower than 
unity. Faster consumption rates worsen the scenario, and NHy-FCV linearly decreases with increasing 
Darad,min in the log-log plot shown in Figure 6. Figure 6 shows that the transition between kinetic and 
transport control occurs at a value of Darad,min which increases as the curvature of the construct 
decreases. At any given Ri/δC, the negative slope of the NHy-FCV dependence on Darad,min under 
transport-limited conditions is lower when medium is perfused outwards across the construct. Figure 6 
shows that for Darad,min = 0.2 and Ri/δC = 0.1 cells are well oxygenated in about 90% of the construct 
volume when medium is perfused outwards, whereas the well oxygenated construct volume decreases 
to only about 40% when medium is perfused inwards. rPBBs in which constructs with smaller 
curvature are used, i.e., higher Ri/δC, are generally more robust. In fact, inward medium perfusion or 
the increase of Darad,min as tissue matures (e.g., cells proliferate or differentiate to a phenotype with 
higher metabolic requirements) causes a smaller decrease of NHy-FCV than in the radial perfusion 
culture of constructs with greater curvature, i.e., lower Ri/δC. Figure 6 shows that for Darad,min = 1 and 
Ri/δC = 1 the NHy-FCV decreases ca. 28% from 0.7 to 0.5 upon switching from outward to inward 
medium perfusion, respectively. At the same Darad,min and for Ri/δC = 10, the NHy-FCV is independent 
of the direction of medium perfusion. The smaller NHy-FCV for inward medium perfusion may be 
blamed on the fact that the oxygen-rich feed enters the construct through its outer surface at the 
minimal superficial radial velocity. Under such conditions, the cells located in the construct periphery 
consume oxygen at the highest metabolic rate and have time enough to deplete the medium of oxygen 
and establish steep dissolved oxygen concentration gradients. When medium is perfused outwards, the 
oxygen-rich feed enters the construct through its inner surface at the maximal radial superficial 
velocity. Under such conditions, the cells located in the construct close to the inner hollow cavity 
consume oxygen at the highest metabolic rate but are not given time enough to deplete the medium of 
oxygen, which will be more available to cells located in the construct periphery where medium flows 
at the minimal superficial radial velocity. This leads to the establishment of smoother dissolved 
oxygen concentration profiles along the direction of medium perfusion. The NHy-FCV dependence on 
the minimal radial Damköhler number Darad,min shown in Figure 6 is consistent with that reported by 
Moustafa et al. [66], who showed that higher substrate conversions (i.e., lower substrate 
concentrations) are obtained in rPBRs for industrial applications if the bed of porous inorganic catalyst 
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is perfused inwards when gas-phase reactions with Langmuir-Hinshelwood kinetics take place. The 
model-predicted effect of the direction of flow perfusion is in apparent contrast to the general use of 
inward perfusion in published reports on rPBBs and to Olivier et al. [36], who reported experiments 
showing that inward medium perfusion enhances osteoblastic cell proliferation to a greater extent than 
outward perfusion. In their paper, Olivier et al., raised an important practical issue influencing the 
decision as to whether an rPBB should be perfused with medium outwards or inwards. In fact, many 
cylindrical scaffolds have pores of increasing size towards their periphery [34], causing significant 
reduction of the local specific surface area. If cells attach weakly to the scaffold surface, for its 
chemical nature or for the little surface area available for adhesion, outward medium perfusion may 
exert high enough mechanical stresses to remove the adherent cells and wash them out. When medium 
is perfused inwards, the finer pores in the construct inner regions may act as a sieve and may retain the 
removed cells, thus avoiding cell wash-out. In addition to this, upon assuming that the MG63 
osteoblastic cells used in [36] consume oxygen at 1.33 × 10−18 mol/(s cell), as other immortalized cell 
lines [67], and for a cell concentration of 2.8 × 106 cell/mL, the minimal radial Damköhler number of 
the construct may be estimated to be about Darad,min = 4.5 × 10−4. Figure 6 shows that at such a low 
value of Darad,min the rPBB is operated under kinetic control and the bioreactor performance is 
independent of the direction of medium perfusion. This suggests that cell wash-out may indeed have 
played an important role in making inward medium perfusion enhance the number of cells found in the 
construct after 7 and 28 days of culture to a greater extent than outward perfusion. This effect should 
be seriously considered when the conditions are chosen under which an rPBB is operated. Figure 6 
suggests that, during cell culture in rPBBs, a low Darad,min should be maintained to minimize oxygen 
concentration gradients across the construct. This could be achieved by perfusing thin constructs at 
high maximal radial superficial velocities, vo, for as much as is permitted by cell resistance to shear 
damage. It suggests also that, as tissue matures, increasing vo may balance out the increase of cell 
metabolic activity caused by cell proliferation and differentiation. 
Figure 6. Model-predicted dependence on Darad,min of the NHy-FCV of 3D porous hollow 
cylindrical constructs featuring varying wall curvature, Ri/δC, in an rPBB when radially 
perfused with medium outwards (γ = 1, solid lines), or inwards (γ = −1, dashed lines). 
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It is important to recall that model predictions are as good as the assumptions upon which the model 
is based. An important assumption on transport is that medium perfuses the construct at a uniform 
superficial velocity along its length. Axial variations of the porous structure of the scaffold may make 
its Darcy permeability significantly vary along the construct length and may cause superficial radial 
velocity maldistribution. In the use of rPBBs for human cell culture, the flow maldistribution would 
cause a non-uniform supply of dissolved oxygen, nutrients and biochemical cues to cells that, in time, 
might yield a non-uniform distribution of cells and cell activities. This way, cells would synthesize and 
deposit the own extracellular matrix non-uniformly in the construct worsening even further the radial 
flow maldistribution and its effects. Additional phenomena possibly affecting the transport and the 
actual concentration of larger solutes (e.g., the physical adsorption of proteins to the scaffold) have 
also been neglected on the account of the low molecular weight and high mobility of oxygen. With 
respect to cell metabolism, the model proposes a description limited to oxygen consumption and its 
dependence on the dissolved oxygen concentration. Work is under way to include in the model other 
metabolic activities and substrates relevant to given therapeutic applications, and the effects on cell 
metabolism of physical cues (e.g., shear stress) [68] and the accumulation of metabolic wastes  
(e.g., lactate). A word of caution is also in order concerning the fact that the value of condensed 
performance parameters such as NHy-FCV and the shape of diagrams such as that shown in Figure 6 
strongly depend on the threshold value set for the dissolved oxygen concentration below which cells 
become apoptotic or die. 
4. Conclusions 
The use of radial flow packed-bed bioreactors (rPBBs) for therapeutic applications may be 
advantageous to overcome the typical limitations of static and axial perfusion bioreactors. In this 
paper, a reference model framework is proposed to help bioreactor designers optimize geometry and 
operation of rPBBs to meet given therapeutic requirements. The framework is based on a model in 
which transport across an annular cell-seeded construct is described according to the Darcy and the 
dispersion-convection-reaction equations. Dimensional analysis was used to combine more effectively 
geometric and operational variables in the dimensionless groups determining the rPBB performance. 
Their effect was investigated on bioreactor performance. The effectiveness of cell oxygenation was 
also expressed in terms of the non-hypoxic fractional construct volume (NHy-FCV), which was 
deemed more apt than other integral performance parameters used in technical applications. Model 
predictions suggest that outward radial perfusion of a 3D porous hollow cylindrical construct with 
small curvature (i.e., high inner hollow cavity radius-to-annular thickness ratio) at high perfusion flow 
rates (i.e., high maximal radial Peclet numbers) may be more convenient than culture in static or axial 
perfusion bioreactors. In fact, this would enable effective oxygenation of human cells also in  
large-scale constructs and culture at more controllable (e.g., more uniform) concentration profiles of 
dissolved oxygen and biochemical cues, at tolerable pressure drops. In conclusion, culture of human 
cell-seeded constructs in perfused rPBBs may permit robust control of the pericellular environment, 
and guidance of cell proliferation and differentiation in the engineering of biological substitutes. These 
features make rPBBs suitable for therapeutic treatments as well as for the in vitro toxicity screening of 
drugs. However, model predictions are as good as the assumptions upon which the model is based. In 
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designing an rPBB with the model proposed, care should be taken to use model parameters estimated 
from culture experiments and to verify that the model assumptions hold true for the specific case 
considered. It should also be noted that the value of integral performance parameters, such as  
NHy-FCV, and diagrams such as that shown in Figure 6 strongly depend on the threshold value set for 
the dissolved oxygen concentration below which cells become apoptotic or die. 
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